Clinical Trial: First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas

Study Status: Terminated
Recruit Status: Unknown status
Study Type: Interventional




Official Title: First Clinical Study of Erbium-YAG Laser Vaporisation of Cutaneous Neurofibromas

Brief Summary: The purpose of this study is to determine whether multiple cutaneous neurofibromas in patients with neurofibromatosis type 1 can be removed with an erbium-YAG-laser.